Subscribe
shutterstock_1533140117_michael_vi
Michael Vi / Shutterstock.com
19 September 2023BiotechnologySarah Speight

10x Genomics 'overjoyed' to win UPC preliminary injunction

Decision marks first announcement by the UPC of an injunction in open court | Ruling in Munich Local Division forecast to have far-reaching consequences for defendant | Comment from 10x vice president of IP and litigation, Randy Wu.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
‘The EPO can manage it—I’m baffled why the UPC can’t’: Test case challenges court’s ‘request for access’ rule
28 November 2023   Is the court’s public access rule unfit for purpose? Lawyers at Mathys & Squire are arguing for pleadings and evidence to be automatically made available on request, finds Muireann Bolger.
Big Pharma
UPC confirms dates for 10x Genomics hearings
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Americas
Munich court rules for Bio-Rad in 10x Genomics dispute
3 December 2019   California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Europe
‘The EPO can manage it—I’m baffled why the UPC can’t’: Test case challenges court’s ‘request for access’ rule
28 November 2023   Is the court’s public access rule unfit for purpose? Lawyers at Mathys & Squire are arguing for pleadings and evidence to be automatically made available on request, finds Muireann Bolger.
Big Pharma
UPC confirms dates for 10x Genomics hearings
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Americas
Munich court rules for Bio-Rad in 10x Genomics dispute
3 December 2019   California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.

More on this story

Europe
‘The EPO can manage it—I’m baffled why the UPC can’t’: Test case challenges court’s ‘request for access’ rule
28 November 2023   Is the court’s public access rule unfit for purpose? Lawyers at Mathys & Squire are arguing for pleadings and evidence to be automatically made available on request, finds Muireann Bolger.
Big Pharma
UPC confirms dates for 10x Genomics hearings
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Americas
Munich court rules for Bio-Rad in 10x Genomics dispute
3 December 2019   California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB